206 related articles for article (PubMed ID: 27956007)
1. High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
Heidegger I; Oberaigner W; Horninger W; Pichler R
Urol Oncol; 2017 Apr; 35(4):152.e1-152.e5. PubMed ID: 27956007
[TBL] [Abstract][Full Text] [Related]
2. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
[TBL] [Abstract][Full Text] [Related]
3. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
4. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
Dell'Atti L
Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
[TBL] [Abstract][Full Text] [Related]
5. Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
Tanaka T; Koie T; Ohyama C; Hashimoto Y; Imai A; Tobisawa Y; Hatakeyama S; Yamamoto H; Yoneyama T; Horiguchi H; Kodama H; Yoneyama T
Jpn J Clin Oncol; 2017 Nov; 47(11):1078-1082. PubMed ID: 28973396
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
Pignot G; Salomon L; Neuzillet Y; Masson-Lecomte A; Lebacle C; Patard JJ; Lunardi P; Rischmann P; Pasticier G; Bernhard JC; Cohen J; Timsit MO; Verkarre V; Peyronnet B; Verhoest G; Le Goux C; Zerbib M; Brecheteau F; Bigot P; Larre S; Murez T; Thuret R; Lacarriere E; Champy C; Roupret M; Comperat E; Berger J; Descazeaud A; Toledano H; Bastide C; Lavilledieu S; Avances C; Delage F; Valeri A; Molimard B; Houlgatte A; Gres P; Donnaint A; Kleinclauss F; Legal S; Doerfler A; Koutlidis N; Cormier L; Hetet JF; Colls P; Arvin-Berod A; Rambeaud JJ; Quintens H; Soulie M; Pfister C;
Ann Surg Oncol; 2014 Feb; 21(2):684-90. PubMed ID: 24170436
[TBL] [Abstract][Full Text] [Related]
7. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
8. Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.
Spahn M; Morlacco A; Boxler S; Joniau S; Briganti A; Montorsi F; Gontero P; Bader P; Frohneberg D; van Poppel H; Karnes RJ;
BJU Int; 2017 Nov; 120(5B):E52-E58. PubMed ID: 28220605
[TBL] [Abstract][Full Text] [Related]
9. Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.
Malte R; Kluth LA; Kaushik D; Boorjian SA; Abufaraj M; Foerster B; Rink M; Gust K; Roghmann F; Noldus J; Vordos D; Hagiwara M; Kikuchi E; Ikeda M; Matsumoto K; Karakiewicz PI; Rouprêt M; Briganti A; Scherr DS; Shariat SF; Seebacher V
Eur J Surg Oncol; 2017 Nov; 43(11):2193-2199. PubMed ID: 28928012
[TBL] [Abstract][Full Text] [Related]
10. Incidental prostate cancer in radical cystoprostatectomy specimens.
Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
[TBL] [Abstract][Full Text] [Related]
11. Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
Thomas C; Giesswein A; Hainz M; Stein R; Rubenwolf P; Roos FC; Neisius A; Nestler S; Hampel C; Jäger W; Wiesner C; Thüroff JW
Int Urol Nephrol; 2015 Nov; 47(11):1789-96. PubMed ID: 26377495
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
Tang S; Hao H; Fang D; Zheng W; Ge P; Su X; He Q; Yang X; Shen Q; Li X; Yu W; Lin J; Zhou L
Int Braz J Urol; 2018; 44(2):258-266. PubMed ID: 29219277
[TBL] [Abstract][Full Text] [Related]
13. Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?
Gakis G; Stenzl A; Renninger M
Scand J Urol; 2013 Oct; 47(5):358-62. PubMed ID: 23078550
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
15. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic influence of prostate gland invasion by bladder tumour and/or prostate cancer in cystoprostatectomy specimen: a review].
Champy CM; Phé V; Drouin SJ; Comperat E; Parra J; Vaessen C; Mozer P; Bitker MO; Rouprêt M
Prog Urol; 2013 Mar; 23(3):165-70. PubMed ID: 23446280
[TBL] [Abstract][Full Text] [Related]
18. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
[TBL] [Abstract][Full Text] [Related]
20. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
